Alphagan-P
INDICATIONS
ALPHAGANÒ P is indicated for the lowering of intraocular pressure in patients with open-angle glaucoma or ocular hypertension.
DOSAGE AND ADMINISTRATION
The recommended dose is one drop of ALPHAGANÒ P in the affected eye(s) three times daily, approximately 8 hours apart.
ALPHAGANÒ P may be used concomitantly with other topical ophthalmic drug products to lower intraocular pressure. If more than one topical ophthalmic product is being used, the products should be administered at least 5 minutes apart.
HOW SUPPLIED
ALPHAGANÒ P is supplied sterile in opaque teal LDPE plastic bottles and droppers with purple high impact polystyrene (HIPS) caps as follows:
| 0.1% | |
| 5 mL in 10 mL bottle | NDC 0023-9321-05 |
| 10 mL in 10 mL bottle | NDC 0023-9321-10 |
| 15 mL in 15 mL bottle | NDC 0023-9321-15 |
| 0.15% | |
| 5 mL in 10 mL bottle | NDC 0023-9177-05 |
| 10 mL in 10 mL bottle | NDC 0023-9177-10 |
| 15 mL in 15 mL bottle | NDC 0023-9177-15 |
NOTE: Store at 15°-25°C (59-77°F).
Rx Only
Ò ALLERGAN
Ó2005 Allergan, Inc
0.1%-9541X
0.15%-9174X
Irvine, CA 92612, U.S.A.
Ò Marks owned by Allergan
US Patent 5,424,078; 5,736,165; 6,194,415; 6,248,741
FDA revision date:5/22/06
Generic Name: Brimonidine Tartrate
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
WebMD Daily
Get breaking medical news.
Glaucoma Laser Treatment
Glaucoma is a sight-stealing condition caused by pressure in the eye. Now patients are finding results through glaucoma laser treatment. See more WebMD Videos »
Alphagan-P
Health Resources
2008 Election & Health Care on WebMD. Get Informed.
Updated & New
RxList does not provide medical advice, diagnosis or treatment.